CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis

[1]  M. Suárez-Fariñas,et al.  The tryptophan metabolism enzyme L-kynureninase is a novel inflammatory factor in psoriasis and other inflammatory diseases. , 2016, The Journal of allergy and clinical immunology.

[2]  J. Bergman,et al.  Evidence for New Light-Independent Pathways for Generation of the Endogenous Aryl Hydrocarbon Receptor Agonist FICZ. , 2016, Chemical research in toxicology.

[3]  H. Uchi,et al.  Gene regulation of filaggrin and other skin barrier proteins via aryl hydrocarbon receptor. , 2015, Journal of dermatological science.

[4]  C. Clish,et al.  Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α , 2015, Nature Medicine.

[5]  S. Amin,et al.  Genetic and pharmacological analysis identifies a physiological role for the AHR in epidermal differentiation , 2015, The Journal of investigative dermatology.

[6]  Y. Li,et al.  IL-22 Fate Reporter Reveals Origin and Control of IL-22 Production in Homeostasis and Infection , 2014, The Journal of Immunology.

[7]  Frank O. Nestle,et al.  Activation of the Aryl Hydrocarbon Receptor Dampens the Severity of Inflammatory Skin Conditions , 2014, Immunity.

[8]  Mayte Suárez-Fariñas,et al.  Immunology of psoriasis. , 2014, Annual review of immunology.

[9]  B. Silva-Santos,et al.  Molecular Mechanisms of Differentiation of Murine Pro-Inflammatory γδ T Cell Subsets , 2013, Front. Immunol..

[10]  Scott N. Mueller,et al.  The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin , 2013, Nature Immunology.

[11]  Pilar Martín,et al.  Is CD69 an effective brake to control inflammatory diseases? , 2013, Trends in molecular medicine.

[12]  S. Hirakawa,et al.  Serum interleukin‐22 and vascular endothelial growth factor serve as sensitive biomarkers but not as predictors of therapeutic response to biologics in patients with psoriasis , 2013, The Journal of dermatology.

[13]  S. Kõks,et al.  Copy number variations in IL22 gene are associated with Psoriasis vulgaris. , 2013, Human immunology.

[14]  Linda V. Sinclair,et al.  Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation , 2013, Nature Immunology.

[15]  S. Werner,et al.  Aldara activates TLR7-independent immune defence , 2013, Nature Communications.

[16]  S. Rutz,et al.  IL‐22, not simply a Th17 cytokine , 2013, Immunological reviews.

[17]  David K. Finlay,et al.  PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells , 2012, The Journal of experimental medicine.

[18]  S. Raychaudhuri,et al.  IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade. , 2012, Cytokine.

[19]  B. Becher,et al.  Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice. , 2012, The Journal of clinical investigation.

[20]  Subhashis Banerjee,et al.  Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. , 2012, The New England journal of medicine.

[21]  H. Kestler,et al.  CD69 Regulates Type I IFN-Induced Tolerogenic Signals to Mucosal CD4 T Cells That Attenuate Their Colitogenic Potential , 2012, The Journal of Immunology.

[22]  Liang Zhou,et al.  The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. , 2012, Immunity.

[23]  V. Jala,et al.  Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. , 2011, Immunity.

[24]  J. Renauld,et al.  IL-22 Is Required for Imiquimod-Induced Psoriasiform Skin Inflammation in Mice , 2011, The Journal of Immunology.

[25]  A. Hayday,et al.  Identification of a Novel Proinflammatory Human Skin-Homing Vγ9Vδ2 T Cell Subset with a Potential Role in Psoriasis , 2011, The Journal of Immunology.

[26]  R. Kageyama,et al.  Notch-Hes1 pathway is required for the development of IL-17-producing γδ T cells. , 2011, Blood.

[27]  L. Ng,et al.  Cutaneous immunosurveillance by self-renewing dermal γδ T cells , 2011, The Journal of experimental medicine.

[28]  A. Blauvelt,et al.  IL-23–Mediated Psoriasis-Like Epidermal Hyperplasia Is Dependent on IL-17A , 2011, The Journal of Immunology.

[29]  Pilar Martín,et al.  CD69 Limits the Severity of Cardiomyopathy After Autoimmune Myocarditis , 2010, Circulation.

[30]  Pilar Martín,et al.  CD69 Association with Jak3/Stat5 Proteins Regulates Th17 Cell Differentiation , 2010, Molecular and Cellular Biology.

[31]  Pilar Martín,et al.  The leukocyte activation antigen CD69 limits allergic asthma and skin contact hypersensitivity. , 2010, The Journal of allergy and clinical immunology.

[32]  M. Veldhoen,et al.  Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. , 2009, Immunity.

[33]  V. Kuchroo,et al.  Cutting Edge: IL-23 Receptor GFP Reporter Mice Reveal Distinct Populations of IL-17-Producing Cells1 , 2009, The Journal of Immunology.

[34]  H. Volk,et al.  IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not , 2009, Journal of Molecular Medicine.

[35]  A. Hayday,et al.  CD27 is a thymic determinant of the balance between interferon-γ- and interleukin 17–producing γδ T cell subsets , 2009, Nature Immunology.

[36]  V. Ganapathy,et al.  Regulatory mechanisms of SNAT2, an amino acid transporter, in L6 rat skeletal muscle cells by insulin, osmotic shock and amino acid deprivation , 2009, Amino Acids.

[37]  M. Veldhoen,et al.  Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells , 2009, The Journal of experimental medicine.

[38]  Kathleen M. Smith,et al.  IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesis , 2006, The Journal of experimental medicine.

[39]  K. Asadullah,et al.  IL‐22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis , 2006, European journal of immunology.

[40]  Naděžda Brdičková,et al.  CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs , 2006, Nature.

[41]  A. Gurney,et al.  IL-22 Inhibits Epidermal Differentiation and Induces Proinflammatory Gene Expression and Migration of Human Keratinocytes1 , 2005, The Journal of Immunology.

[42]  E. Esplugues,et al.  CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis. , 2003, The Journal of clinical investigation.

[43]  M. Ginsberg,et al.  Distinct Domains of CD98hc Regulate Integrins and Amino Acid Transport* , 2001, The Journal of Biological Chemistry.

[44]  F. Sánchez‐Madrid,et al.  Phenotypic and functional characteristics of hematopoietic cell lineages in CD69-deficient mice. , 2000, Blood.

[45]  Mark Lebwohl,et al.  Psoriasis , 1906, The Lancet.

[46]  P. Taylor.  Role of amino acid transporters in amino acid sensing. , 2014, The American journal of clinical nutrition.

[47]  G. Galbraith.  Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis , 2008 .

[48]  M. Mukai,et al.  Effects of tryptophan photoproducts in the circadian timing system: searching for a physiological role for aryl hydrocarbon receptor. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.